Bank of New York Mellon’s Cumberland Pharmaceuticals CPIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $379K | Hold |
58,458
| – | – | ﹤0.01% | 3881 |
|
|
2026
Q1 | $190K | Sell |
58,458
-14,055
| -19% | -$54.2K | ﹤0.01% | 4014 |
|
|
2025
Q4 | $289K | Hold |
72,513
| – | – | ﹤0.01% | 3882 |
|
|
2025
Q3 | $226K | Hold |
72,513
| – | – | ﹤0.01% | 3968 |
|
|
2025
Q2 | $243K | Hold |
72,513
| – | – | ﹤0.01% | 3901 |
|
|
2025
Q1 | $307K | Sell |
72,513
-2,756
| -4% | -$11.4K | ﹤0.01% | 3696 |
|
|
2024
Q4 | $178K | Buy |
75,269
+1
| +0% | +$1 | ﹤0.01% | 3973 |
|
|
2024
Q3 | $96.3K | Hold |
75,268
| – | – | ﹤0.01% | 4009 |
|
|
2024
Q2 | $115K | Hold |
75,268
| – | – | ﹤0.01% | 4017 |
|
|
2024
Q1 | $126K | Hold |
75,268
| – | – | ﹤0.01% | 4010 |
|
|
2023
Q4 | $135K | Hold |
75,268
| – | – | ﹤0.01% | 4035 |
|
|
2023
Q3 | $142K | Buy |
+75,268
| New | +$126K | ﹤0.01% | 4038 |
|
|
2022
Q2 | – | Sell |
-19,843
| Closed | -$56K | – | 4605 |
|
|
2022
Q1 | $56K | Hold |
19,843
| – | – | ﹤0.01% | 4504 |
|
|
2021
Q4 | $93K | Hold |
19,843
| – | – | ﹤0.01% | 4410 |
|
|
2021
Q3 | $53K | Hold |
19,843
| – | – | ﹤0.01% | 4430 |
|
|
2021
Q2 | $56K | Hold |
19,843
| – | – | ﹤0.01% | 4312 |
|
|
2021
Q1 | $60K | Sell |
19,843
-371
| -2% | -$1.21K | ﹤0.01% | 4232 |
|
|
2020
Q4 | $60K | Hold |
20,214
| – | – | ﹤0.01% | 4135 |
|
|
2020
Q3 | $65K | Hold |
20,214
| – | – | ﹤0.01% | 3992 |
|
|
2020
Q2 | $67K | Hold |
20,214
| – | – | ﹤0.01% | 3940 |
|
|
2020
Q1 | $74K | Hold |
20,214
| – | – | ﹤0.01% | 3905 |
|
|
2019
Q4 | $104K | Hold |
20,214
| – | – | ﹤0.01% | 4019 |
|
|
2019
Q3 | $120K | Hold |
20,214
| – | – | ﹤0.01% | 3998 |
|
|
2019
Q2 | $128K | Hold |
20,214
| – | – | ﹤0.01% | 3995 |
|
|
2019
Q1 | $118K | Sell |
20,214
-124
| -0.6% | -$719 | ﹤0.01% | 3976 |
|
|
2018
Q4 | $123K | Hold |
20,338
| – | – | ﹤0.01% | 3932 |
|
|
2018
Q3 | $116K | Hold |
20,338
| – | – | ﹤0.01% | 4016 |
|
|
2018
Q2 | $125K | Sell |
20,338
-4,500
| -18% | -$28.1K | ﹤0.01% | 3979 |
|
|
2018
Q1 | $166K | Buy |
24,838
+4,500
| +22% | +$31K | ﹤0.01% | 3964 |
|
|
2017
Q4 | $150K | Hold |
20,338
| – | – | ﹤0.01% | 4009 |
|
|
2017
Q3 | $143K | Hold |
20,338
| – | – | ﹤0.01% | 3935 |
|
|
2017
Q2 | $142K | Hold |
20,338
| – | – | ﹤0.01% | 3963 |
|
|
2017
Q1 | $141K | Hold |
20,338
| – | – | ﹤0.01% | 3957 |
|
|
2016
Q4 | $112K | Sell |
20,338
-258
| -1% | -$1.35K | ﹤0.01% | 4012 |
|
|
2016
Q3 | $103K | Sell |
20,596
-738
| -3% | -$3.47K | ﹤0.01% | 4032 |
|
|
2016
Q2 | $96K | Hold |
21,334
| – | – | ﹤0.01% | 4065 |
|
|
2016
Q1 | $96K | Hold |
21,334
| – | – | ﹤0.01% | 3969 |
|
|
2015
Q4 | $112K | Sell |
21,334
-25
| -0.1% | -$142 | ﹤0.01% | 4032 |
|
|
2015
Q3 | $123K | Buy |
21,359
+25
| +0.1% | +$156 | ﹤0.01% | 4056 |
|
|
2015
Q2 | $153K | Buy |
21,334
+3,216
| +18% | +$22.4K | ﹤0.01% | 3952 |
|
|
2015
Q1 | $121K | Buy |
18,118
+1,475
| +9% | +$9.21K | ﹤0.01% | 4003 |
|
|
2014
Q4 | $99K | Buy |
16,643
+300
| +2% | +$1.54K | ﹤0.01% | 4042 |
|
|
2014
Q3 | $81K | Hold |
16,343
| – | – | ﹤0.01% | 4096 |
|
|
2014
Q2 | $73K | Buy |
16,343
+249
| +2% | +$1.11K | ﹤0.01% | 4033 |
|
|
2014
Q1 | $72K | Hold |
16,094
| – | – | ﹤0.01% | 4040 |
|
|
2013
Q4 | $83K | Sell |
16,094
-1,325
| -8% | -$6.47K | ﹤0.01% | 4051 |
|
|
2013
Q3 | $79K | Buy |
17,419
+1,325
| +8% | +$6.6K | ﹤0.01% | 3990 |
|
|
2013
Q2 | $83K | Buy |
+16,094
| New | +$80.1K | ﹤0.01% | 3964 |
|
Other funds holding CPIX
IC
Bank of New York Mellon's CPIX Position: Q2 2026 in Review
Bank of New York Mellon held its Cumberland Pharmaceuticals (CPIX) position steady in Q2 2026 at 58,458 shares worth $379K. The position accounts for ﹤0.01% of the portfolio, ranked #3881.
Bank of New York Mellon first reported a position in CPIX in Q2 2013 and has held it in 48 quarters since. 29 funds tracked by Wall St. Rank hold CPIX as of Q2 2026.
- Bank of New York Mellon held 58,458 shares of Cumberland Pharmaceuticals worth $379K as of Q2 2026.
- Bank of New York Mellon left its Cumberland Pharmaceuticals share count unchanged in Q2 2026.
- Cumberland Pharmaceuticals made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3881 holding.
- Bank of New York Mellon first reported a position in Cumberland Pharmaceuticals in Q2 2013 and has held it in 48 quarters since.
- 29 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.